Werner Scheuer

USPTO Granted Patents = 22 (Patent Applications = 25)

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 17 (Patent Applications = 20)

Average Co-Inventor Count = 5.4

ph-index = 7

Forward Citations = 162(Granted Patents)

Location History:

Mannheim, DE (1997)
Bad Tolz, DE (1998 - 1999)
Penzberg, DE (1998 - 2023)

Company Filing History:

18 out of 4,942

Hoffmann-la Roche Inc.

patents

3 out of 1,164

Boehringer Mannheim Gmbh

patents

1 out of 1

Boehringer Mannheim Bmbh

patent

Years Active: 1997-2023

Loading Chart...

22 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11787873 - Bispecific HER2 antibodies and methods of use (2023-10-17),

2. 10584178 - Bispecific HER2 antibodies and methods of use (2020-03-10),

3. 9708396 - Bispecific anti-VEGF/anti-ANG-2 antibodies (2017-07-18),

4. 9687568 - Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label (2017-06-27),

5. 9574016 - Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent (2017-02-21),

6. 9340609 - Antibodies against human angiopoietin 2 (2016-05-17),

7. 9339560 - Method for determining the anti-tumor efficacy of monoclonal antibodies (2016-05-17),

8. 9109027 - Antibodies against human angiopoietin 2 (2015-08-18),

9. 9090700 - Tumor therapy with an antibody for vascular endothelial growth factor and an antibody for human epithelial growth factor receptor type 2 (2015-07-28),

10. 9073986 - Antibodies against human angiopoietin 2 (2015-07-07),

11. 9050375 - Bi-specific digoxigenin binding antibodies (2015-06-09),

12. 8907069 - Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent (2014-12-09),

13. 8703130 - Bispecific anti-VEGF/anti-ANG-2 antibodies (2014-04-22),

14. 8529901 - Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label (2013-09-10),

15. 8399626 - Antibodies against human angiopoietin 2 (2013-03-19),

Title: Werner Scheuer - Innovative Inventor from Penzberg

Introduction: Werner Scheuer is a renowned inventor hailing from Penzberg, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Werner Scheuer holds several patents in the areas of renewable energy, sustainable technologies, and advanced materials, showcasing his commitment to innovation.

Career Highlights: With a career spanning over two decades, Werner Scheuer has worked tirelessly to develop cutting-edge solutions that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Werner Scheuer has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Werner Scheuer's passion for innovation and his dedication to creating impactful solutions have solidified his reputation as a visionary inventor in the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.